Showing results (771-780 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|January 8, 2021
Sex disparity in long-term stroke recurrence and mortality in a rural population in the United StatesClare Lambert, Durgesh Chaudhary, Oluwaseyi Olulana, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2026
Single-channel EEG captures tDCS-induced changes in neural reactivity: a pilot study in disorders of consciousness patients and healthy controlsLior Molcho, Neta B Maimon, Nathan Intrator, et al.
Therapeutic Advances in Neurological Disorders|March 14, 2013
Best practice in the use of natalizumab in multiple sclerosisOscar Fernández
Therapeutic Advances in Neurological Disorders|July 2, 2026
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensionsVera Bril, Artur Drużdż, Julian Grosskreutz, et al.
Therapeutic Advances in Neurological Disorders|May 25, 2026
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countriesCarmen de Keijzer, Jian-Yu E, Qian Yang, et al.
Therapeutic Advances in Neurological Disorders|April 24, 2026
Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsMoaz Elsayed Abouelmagd, Abdallah Abbas, Obai Yousef, et al.
Therapeutic Advances in Neurological Disorders|August 6, 2026
Lamotrigine-induced Stevens-Johnson syndrome in the setting of mitochondrial encephalomyopathy: A case reportYe Tian, Teng Chen, Jingwen Liu, et al.
Therapeutic Advances in Neurological Disorders|July 16, 2026
The conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypothesesAnastasia Bougea
Therapeutic Advances in Neurological Disorders|July 27, 2026
Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosisMathia Kirstein, Niklas Frahm, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|August 1, 2026
Cerebral small vessel disease impairs dynamic cerebral autoregulation and mediates outcomes after stroke thrombectomyYue Qiao, Ran Liu, Lupei Cai, et al.
Pageof 108